<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962505</url>
  </required_header>
  <id_info>
    <org_study_id>668259</org_study_id>
    <nct_id>NCT02962505</nct_id>
  </id_info>
  <brief_title>Continuous Regional Analysis Device for Neonate Lung</brief_title>
  <acronym>CRADL</acronym>
  <official_title>Continuous Regional Analysis Device for Neonate Lung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Middlesex University London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NICU of Makarios III Hospital-The Ministry of Health for the Republic of Cyprus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bio-Medical Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linneuniversitetet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SWISSTOM AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Studio Fifield</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Panaxea B.V.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess whether Electrical Impedance Tomography (EIT) has the
      potential to optimize the ventilator therapy, validate the effectiveness, efficacy and safety
      of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant
      therapy, recruitment manoeuvres, etc.) and for early recognition of complications like
      pneumothorax and endotracheal tube misplacement. The study design is purely observational.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      EIT data will be recorded during 72 hours of routine clinical treatment. To prevent any
      decisions based on EIT information, the clinicians will be blinded to the EIT findings during
      the study period. Data on clinical interventions and clinical findings will be recorded using
      a specially adapted graphical user interface on the EIT device in combination with a
      paper-based case report form (CRF). EIT data analysis will be performed off-line.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in aggregate measure of ventilation homogeneity (coefficient of variation and global inhomogeneity index of regional tidal volume) by &gt; 10% compared with baseline</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in right-to-left and/or anteroposterior ventilation distribution by &gt;10% compared with baseline</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time and duration of right-to-left or left-to-right ventilation ratio &gt;2:1</measure>
    <time_frame>72 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of &lt; 700 Ohm</measure>
    <time_frame>72 hours</time_frame>
    <description>Skin contact impedance will be monitored continuously by the EIT device. If more than 6 sensors exhibit skin contact impedance &gt; 700 Ohm, the examination is no longer suitable for analyzing. To assess the percentage of EIT measurements suitable for analyzing, we will calculate the percentage of EIT examination time with at least 26 out of 32 sensors exhibiting skin contact impedance of less than 700 Ohm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of onset/end of non-invasive respiratory support and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of intubation/extubation and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of suctioning and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time and type of posture change and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of surfactant administration and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of clinically indicated radiological examination and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of recruitment manoeuvre and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of confirmed pneumothorax and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between time of confirmed endotracheal tube malposition and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between primary cause of respiratory failure and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between fraction of inspired oxygen over time and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relationship between saturation of peripheral oxygen over time and EIT findings</measure>
    <time_frame>72 hours</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Infant Respiratory Distress Syndrome</condition>
  <condition>Acute Bronchiolitis</condition>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study specifically focuses on the EIT monitoring of preterm and term neonates, small
        infants and children up to the age of 7 years treated in NICU and PICU as this is the
        population where the need for regional lung function monitoring tools is most urgently
        needed to optimize the ventilator therapy, validate the effectiveness, efficacy and safety
        of nursing and medical interventions (endotracheal suctioning, posture changes, surfactant
        therapy, alveolar recruitment, etc.) and prevent/minimize the occurrence of acute
        (pneumothorax, endotracheal tube misplacement) and chronic (chronic lung disease or
        bronchopulmonary dysplasia) adverse effects.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written, informed consent of both parents or legal representative

          -  Admission in the NICU or PICU

          -  Patients with or at high risk of developing respiratory failure needing respiratory
             support.

             o i.e. (oxygen need (FiO2&gt;25%) AND noninvasive or invasive respiratory support) AND/OR
             repeated apnea with desaturations

          -  Age from birth to 7 years o Initial focus will be on neonates up to 6 kg and 12 months
             age. Infants of higher weight up to 7 years age will be included as EIT belts for this
             age group become available.

        Exclusion Criteria:

          -  Post menstrual age less than 25 weeks

          -  Body weight &lt; 600 g

          -  Electrically active implants

          -  Thorax skin lesions

          -  Prior participation for the same diagnosis of lung disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inez Frerichs, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Medical Center SH, Kiel , Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inez Frerichs, MD</last_name>
    <phone>+4943159720971</phone>
    <email>inez.frerichs@uksh.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tobias Becher, MD</last_name>
    <phone>+4943159720980</phone>
    <email>tobias.becher@uksh.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Archbishop Makarios III Hospital</name>
      <address>
        <city>Nicosia</city>
        <country>Cyprus</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Karaoli</last_name>
      <email>christinakaraoli@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merja Kallio</last_name>
      <email>merja.kallio@oulu.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Papageorgiou Hospital</name>
      <address>
        <city>Thessaloníki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ilias Chatziioannidis</last_name>
      <email>drilias@windowslive.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anton Van Kaam, MD</last_name>
      <email>a.h.vankaam@amc.uva.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VU University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anton van Kaam, MD</last_name>
      <email>a.h.vankaam@amc.uva.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Cyprus</country>
    <country>Finland</country>
    <country>Greece</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>February 13, 2018</last_update_submitted>
  <last_update_submitted_qc>February 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Inez Frerichs</investigator_full_name>
    <investigator_title>Prof. Dr. Inéz Frerichs</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

